Literature DB >> 12873087

Hepatitis B knowledge and practices among Chinese Canadian women in Vancouver, British Columbia.

Matthew J Thompson1, Victoria M Taylor, Yutaka Yasui, T Gregory Hislop, J Carey Jackson, Alan Kuniyuki, Chong Teh.   

Abstract

INTRODUCTION: Liver cancer rates are higher in North American Chinese than non-Asian ethnic/racial groups, largely due to chronic hepatitis B virus (HBV) infection.
METHODS: A community-based survey of Chinese women (n = 147) was completed during 1999 to examine HBV knowledge and practices in Vancouver, British Columbia.
RESULTS: Most women had heard of HBV (85%) but smaller proportions knew about some routes of transmission (e.g., sexual intercourse) and sequelae of infection. Knowledge about HBV was significantly associated with education level (p = 0.005), English fluency (p < 0.001) and household income (p = 0.007). Previous serologic testing for HBV infection was significantly associated with education level (p = 0.04), English fluency (p = 0.01), and level of knowledge about HBV (p < 0.001).
CONCLUSIONS: Efforts to increase knowledge about HBV infection in this community should consider targeting less educated and less acculturated individuals.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12873087

Source DB:  PubMed          Journal:  Can J Public Health        ISSN: 0008-4263


  36 in total

1.  The sociocultural health behavioral model and disparities in colorectal cancer screening among Chinese Americans.

Authors:  Grace X Ma; Min Qi Wang; Xiang S Ma; Giyeon Kim; Jamil Toubbeh; Steven Shive
Journal:  J Nurs Educ Pract       Date:  2013

2.  Attitudes toward hepatitis B virus among Vietnamese, Chinese and Korean Americans in the Houston area, Texas.

Authors:  Jessica P Hwang; Aimee K Roundtree; Maria E Suarez-Almazor
Journal:  J Community Health       Date:  2012-10

3.  Feasibility and Acceptability of an English-as-a-Second Language Curriculum on Hepatitis B for Older Chinese American Immigrants.

Authors:  Gloria D Coronado; Elizabeth Acorda; H Hoai Do; Victoria M Taylor
Journal:  J Health Dispar Res Pract       Date:  2008

4.  Misperceptions among patients with chronic hepatitis B in Singapore.

Authors:  Chun-Tao Wai; Belinda Mak; Winnie Chua; Mei-Hua Tan; Seline Ng; Amelia Cheok; Mee-Lian Wong; Seng-Gee Lim
Journal:  World J Gastroenterol       Date:  2005-08-28       Impact factor: 5.742

5.  Role of sociocultural factors in hepatitis B screening among Asian Americans.

Authors:  Grace X Ma; Sunmin Lee; Min Wang; Yin Tan; Wanzhen Gao; Xiang Ma; Philip Lai; Jamil I Toubbeh
Journal:  South Med J       Date:  2011-07       Impact factor: 0.954

6.  Inequality in the hepatitis B awareness level in rural residents from 7 provinces in China.

Authors:  Juan Zheng; Quan Li; Jian Wang; Guojie Zhang; Knut R Wangen
Journal:  Hum Vaccin Immunother       Date:  2017-02-14       Impact factor: 3.452

7.  Sociocultural factors that potentially affect the institution of prevention and treatment strategies for prevention of hepatitis B in Chinese Canadians.

Authors:  Harry Wu; Colina Yim; Alex Chan; Michael Ho; Jenny Heathcote
Journal:  Can J Gastroenterol       Date:  2009-01       Impact factor: 3.522

8.  Provider knowledge and practice regarding hepatitis B screening in Chinese-speaking patients.

Authors:  Cindy J Lai; Tung T Nguyen; Jimmy Hwang; Susan L Stewart; Anson Kwan; Stephen J McPhee
Journal:  J Cancer Educ       Date:  2007       Impact factor: 2.037

9.  Awareness, knowledge and self-reported test rates regarding Hepatitis B in Turkish-Dutch: a survey.

Authors:  Ytje Jj van der Veen; Hélène Acm Voeten; Onno de Zwart; Jan Hendrik Richardus
Journal:  BMC Public Health       Date:  2010-08-24       Impact factor: 3.295

10.  Hepatitis B screening in the Turkish-Dutch population in Rotterdam, the Netherlands; qualitative assessment of socio-cultural determinants.

Authors:  Ytje Jj van der Veen; Onno de Zwart; Hélène Acm Voeten; Johan P Mackenbach; Jan Hendrik Richardus
Journal:  BMC Public Health       Date:  2009-09-09       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.